ATE123813T1 - Tierische interferone, verfahren bei deren herstellung, dieselben enthaltende zusammensetzungen, kodierende dns-sequenzen hierfür und diese sequenzen enthaltende expressionsvektoren und dadurch transformierte zellen. - Google Patents

Tierische interferone, verfahren bei deren herstellung, dieselben enthaltende zusammensetzungen, kodierende dns-sequenzen hierfür und diese sequenzen enthaltende expressionsvektoren und dadurch transformierte zellen.

Info

Publication number
ATE123813T1
ATE123813T1 AT83301208T AT83301208T ATE123813T1 AT E123813 T1 ATE123813 T1 AT E123813T1 AT 83301208 T AT83301208 T AT 83301208T AT 83301208 T AT83301208 T AT 83301208T AT E123813 T1 ATE123813 T1 AT E123813T1
Authority
AT
Austria
Prior art keywords
sequences
production
processes
expression vectors
same
Prior art date
Application number
AT83301208T
Other languages
English (en)
Inventor
Daniel Jeffrey Capon
David Vannorman Goeddel
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE123813T1 publication Critical patent/ATE123813T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT83301208T 1982-03-08 1983-03-07 Tierische interferone, verfahren bei deren herstellung, dieselben enthaltende zusammensetzungen, kodierende dns-sequenzen hierfür und diese sequenzen enthaltende expressionsvektoren und dadurch transformierte zellen. ATE123813T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35529882A 1982-03-08 1982-03-08
US43812882A 1982-11-01 1982-11-01

Publications (1)

Publication Number Publication Date
ATE123813T1 true ATE123813T1 (de) 1995-06-15

Family

ID=26998783

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83301208T ATE123813T1 (de) 1982-03-08 1983-03-07 Tierische interferone, verfahren bei deren herstellung, dieselben enthaltende zusammensetzungen, kodierende dns-sequenzen hierfür und diese sequenzen enthaltende expressionsvektoren und dadurch transformierte zellen.

Country Status (17)

Country Link
EP (1) EP0088622B1 (de)
JP (4) JP2633227B2 (de)
AT (1) ATE123813T1 (de)
AU (1) AU572447B2 (de)
CA (1) CA1339936C (de)
DD (1) DD207732A5 (de)
DE (2) DE3308030C2 (de)
DK (1) DK171790B1 (de)
ES (2) ES520358A0 (de)
FR (1) FR2530662B1 (de)
GB (1) GB2116566B (de)
IE (1) IE54592B1 (de)
IL (1) IL68059A (de)
NZ (1) NZ203493A (de)
PL (1) PL153902B1 (de)
PT (1) PT76353B (de)
YU (1) YU46722B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58146281A (ja) * 1981-10-19 1983-08-31 Suntory Ltd 酵母細胞の形質転換法
US4751287A (en) * 1983-02-24 1988-06-14 Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr Human leukocyte interferon N and a method of producing same in bacterial cells
ZA843275B (en) * 1983-05-05 1984-12-24 Hoffmann La Roche Novel vectors for interferon expression
EP0162898A4 (de) * 1983-11-14 1987-07-23 Chiron Corp Interleukin-2-erzeugung unter verwendung klonierter gene für interleukin-2 und hefe alpha-faktor.
IL71555A (en) * 1984-04-15 1992-06-21 State Of Israel Israel Inst Fo Bovine interferon
US4855231A (en) * 1984-10-30 1989-08-08 Phillips Petroleum Company Regulatory region for heterologous gene expression in yeast
FI90990C (fi) * 1984-12-18 1994-04-25 Boehringer Ingelheim Int Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
DE3500961A1 (de) * 1985-01-14 1986-07-17 Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig Escherichia-coli-staemme, dna-teilsequenzen dieser staemme und herstellungsverfahren
US4882282A (en) * 1985-08-16 1989-11-21 Immunex Corporation DNA sequences encoding bovine interleukin-2
US4709324A (en) * 1985-11-27 1987-11-24 Motorola, Inc. Data processor control unit having an interrupt service using instruction prefetch redirection
ZA877924B (en) * 1985-12-04 1987-08-26 Immunex Corp Cloning,characterization,and expression of bovine gamma interferon
DE3642096A1 (de) * 1986-12-10 1988-06-16 Boehringer Ingelheim Int Pferde-(gamma)-interferon
ES2053585T3 (es) * 1986-12-12 1994-08-01 Ciba Geigy Ag Utilizacion de interferon-alfa bovino en la obtencion de un medicamento para el tratamiento profilactico de las vacas contra las enfermedades comprendidas bajo el termino generico de complejo de gripe bovina.
DE3853523T2 (de) * 1987-12-29 1995-08-17 Toray Industries Synthetisches Plasmid, transformierte Zelle, Katzen-Interferon-Gen und Verfahren zur Herstellung von Katzen-Interferon.
WO1989009065A1 (en) * 1988-03-23 1989-10-05 University Of Georgia Research Foundation, Inc. Large-scale production of bovine leukocyte interferon
CA2019803C (en) * 1989-06-29 2000-04-25 Akira Yanai Feline interferon and process for production thereof
US5885567A (en) * 1993-10-22 1999-03-23 University Of Connecticut Treatment of infection in fowl by oral administration of avian interferon proteins
US5641656A (en) * 1993-10-22 1997-06-24 University Of Connecticut Nucleic acids encoding avian interferon (IFN) proteins and recombinant methods using them
FR2825716B1 (fr) 2001-06-11 2004-09-24 Genodyssee Nouveaux polynucleotides et polypeptides de l'ifn alpha 7
BR0314542A (pt) * 2002-10-08 2005-07-26 Dow Agrosciences Llc Células recombinantes emendadas (arcs) para a produção e liberação de agentes antivirais, adjuvantes e acelerados de vacina
US20040219131A1 (en) * 2002-11-18 2004-11-04 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
CN109206502B (zh) * 2018-09-26 2022-03-04 东北农业大学 一种猫干扰素ω及其制备方法和在抗病毒中的应用
CN112457391B (zh) * 2020-11-02 2022-10-04 天津大学 猪干扰素α、β、λ1在酿酒酵母中共分泌表达的方法及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980002375A1 (en) * 1977-09-23 1980-11-13 Hem Res Inc High purity animal interferons
JPS56131598A (en) * 1980-03-19 1981-10-15 Japan Found Cancer Novel recombinant plasmid having gene of human fibroblastic interferon messenger rna
FI77877C (fi) * 1979-04-20 1989-05-10 Technobiotic Ltd Foerfarande foer framstaellning och rening av human le-formig interferonprotein.
US4262090A (en) * 1979-06-04 1981-04-14 Cetus Corporation Interferon production
IL58765A (en) * 1979-11-21 1986-09-30 Yeda Res & Dev Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
US4530901A (en) * 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
CY1346A (en) * 1980-01-08 1987-01-16 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human interferon-like polypeptides
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
DE3005843A1 (de) * 1980-02-16 1981-09-10 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
EP0042246B1 (de) * 1980-06-12 1987-03-18 The Cancer Institute Of Japanese Foundation For Cancer Research Plasmid
CH651308A5 (de) * 1980-07-01 1985-09-13 Hoffmann La Roche Interferone und deren herstellung.
FR2490675B1 (fr) * 1980-09-25 1985-11-15 Genentech Inc Production microbienne d'interferon de fibroplaste humain
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna

Also Published As

Publication number Publication date
DD207732A5 (de) 1984-03-14
AU572447B2 (en) 1988-05-12
EP0088622B1 (de) 1995-06-14
FR2530662A1 (fr) 1984-01-27
ES8500327A1 (es) 1984-11-01
FR2530662B1 (fr) 1985-11-15
YU55583A (en) 1986-04-30
JPH06315385A (ja) 1994-11-15
DE3382789T2 (de) 1995-12-14
GB8306225D0 (en) 1983-04-13
GB2116566B (en) 1985-11-27
GB2116566A (en) 1983-09-28
DE3382789D1 (de) 1995-07-20
DE3308030C2 (de) 1996-03-28
IE54592B1 (en) 1989-12-06
EP0088622A3 (en) 1984-08-01
PT76353B (en) 1986-02-27
IL68059A (en) 1990-11-05
JP2633510B2 (ja) 1997-07-23
JPH0948799A (ja) 1997-02-18
ES533485A0 (es) 1986-04-01
ES520358A0 (es) 1984-11-01
EP0088622A2 (de) 1983-09-14
NZ203493A (en) 1987-08-31
DK111183D0 (da) 1983-03-07
AU1212283A (en) 1983-09-15
PL240926A1 (en) 1983-10-24
YU46722B (sh) 1994-04-05
JPS58224690A (ja) 1983-12-27
CA1339936C (en) 1998-06-30
PT76353A (en) 1983-04-01
DK111183A (da) 1983-09-09
JPH08187088A (ja) 1996-07-23
IL68059A0 (en) 1983-06-15
PL153902B1 (en) 1991-06-28
DE3308030A1 (de) 1983-09-29
JP2677759B2 (ja) 1997-11-17
ES8605534A1 (es) 1986-04-01
DK171790B1 (da) 1997-05-26
JP2633227B2 (ja) 1997-07-23
IE830471L (en) 1983-09-08
JP2721139B2 (ja) 1998-03-04

Similar Documents

Publication Publication Date Title
DE3382789D1 (de) Tierische Interferone, Verfahren bei deren Herstellung, dieselben enthaltende Zusammensetzungen, kodierende DNS-Sequenzen hierfür und diese Sequenzen enthaltende Expressionsvektoren und dadurch transformierte Zellen.
ATE142692T1 (de) Herstellung von hämoglobin und analogen davon durch bakterien oder hefen
DE3650538D1 (de) Interleukin-4 protein mit bcgf- und tcgf-aktivität gegenüber menschlichen zellen (menschliches interleukin-4)
ATE45382T1 (de) Biosynthetisch hergestellter humannervenwachstumsfaktor, verfahren zu seiner herstellung, diesen faktor enthaltende zusammensetzungen, diesen faktor codierende dna- sequenz, vektoren, die diese sequenz enthalten und dadurch transformierte wirtszellen.
DE3687763D1 (de) Oxidationsbestaendige il-2-muteine und ihre herstellung, diese muteine enthaltende zusammensetzungen, solche muteine kodierende dns-sequenzen und expressionsvektoren und korrespondierende transformierte wirtzellen.
ATE140960T1 (de) Verfahren zur herstellung von zellen, die stabil integrierte fremde dns mit hoher kopiezahl enthalten, durch dieses verfahren hergestellte zellen und verwendung dieser zellen zur herstellung von durch diese fremde dns kodierten polypeptiden
HK49285A (en) Interferons and process for their preparation
ATE46718T1 (de) Hybride menschliche leukozyten-interferone, verfahren zu deren mikrobieller herstellung, zwischenverbindungen dafuer und dieselben enthaltende zusammensetzungen.
DK0559884T4 (da) Rekombinante virusvektorer til ekspression i muskelceller
DE3584579D1 (de) Herstellung von polypeptiden mit human-gammainterferon-aktivitaet.
ATE62508T1 (de) Partikel mit immunogenen hbs-antigeneigenschaften und mit einer mit dem hbs-antigen- epitopen nichtverwandten antigenischen stelle, vektoren und tierische zellen fuer die herstellung dieser kombinierten impfstoffartikel.
IL88151A (en) Interleukin-7 protein, dna sequences encoding it, its preparation and compositions containing it
DE3751368D1 (de) gentechnische Herstellung von Faktor XIIIa.
ATE47864T1 (de) Verschiedenartige familie von menschlichen leukozyten-interferonen, zusammensetzungen, die diese enthalten, verfahren zu ihrer herstellung, sowie dna und transfektierte wirte hierfuer.
ATA435083A (de) Das polypeptid interleukin-2 kodierendes gen, rekombinante, dieses gen enthaltende dna, diese rekombinante dna aufweisende zellinien und verfahren zur herstellung von interleukin-2 unter verwendung der genannten zellen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time